Bralten, J
van Hulzen, K J
Martens, M B
Galesloot, T E
Arias Vasquez, A
Kiemeney, L A
Buitelaar, J K
Muntjewerff, J W
Franke, B https://orcid.org/0000-0003-4375-6572
Poelmans, G
Article History
Received: 17 October 2016
Revised: 6 February 2017
Accepted: 16 March 2017
First Online: 16 May 2017
Change Date: 20 June 2017
Change Type: Erratum
Change Details: Correction to: Molecular Psychiatry advance online publication, 16 May 2017; doi: 10.1038/mp.2017.98 The following information was omitted from the Acknowledgements : This study was further supported by the Innovative Medicines Initiative (IMI) Joint Undertaking under grant agreement no. 115300 (EU-AIMS), resources of which are composed of financial contribution from the European Community’s Seventh Framework Program (FP7/2007–2013) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) companies' in kind contribution.
Competing interests
: The authors declare no conflict of interest.